List of Oncology Medication For

Blood Disorders

Hematologic diseases are disorders which primarily affect the blood and blood-forming organs. Hematologic diseases include rare genetic disorders, anemia, HIV, sickle cell disease and complications from chemotherapy or transfusions.

If Blood Disorders Medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

hydroxyurea capsules

Leukemia, Head And Neck

hydroxyurea capsules
for oral use Initial U.S. Approval: 1967

hydroxyurea capsules is an antimetabolite indicated for the treatment of: • Resistant chronic myeloid leukemia. • Locally advanced squamous cell carcinomas of the head and neck, (excluding lip) in combination with concurrent chemoradiation.

Facts about hydroxyurea capsules

Approval Date: 1967
Proprietary Name: On Request
Active Ingredient(s): hydroxyurea capsules
Dosage Forms And Strengths: Capsules: 500 mg
Company: Bristol-Myers Squibb
Current indications: chronic myeloid leukemia, head and neck
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import hydroxyurea capsules” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Ibrutinib Capsules

Leukemia

ibrutinib capsules
for oral use Initial U.S. Approval: 2013

Facts about ibrutinib capsules

Approval Date: 2013
Proprietary Name: On Request
Active Ingredient(s): Ibrutinib
Dosage Forms And Strengths: Capsules: 70 mg and 140 mg
Tablets: 140 mg, 280 mg, 420 mg, and 560 mg
Oral suspension: 70 mg/mL
Companies: AbbVie, Johnson & Johnson
Diseases: Imbruvica is indicated for chronic lymphocytic leukemia (CLL), chronic lymphocytic leukemia (CLL) with 17p deletion, Waldenström’s macroglobulinemia (WM) and mantle cell lymphoma (MCL) who have received at least one prior treatment
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ibrutinib capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

ICLUSIG (ponatinib) tablets

Leukemia

Brand: ICLUSIG. API: ponatinib is used to treat blood cancers.

Iclusig (ponatinib) is a prescription tyrosine kinase inhibitor used to treat specific types of blood cancers.

Brand Name:	ICLUSIG – On Request
Generic Name:	ponatinib tablets
Strength:	Tablets: 10 mg, 15 mg, 30 mg and 45 mg.
Manufacturer:	Takeda Pharmaceuticals
Approved By:	EMA, USFDA
Get access to medicines:	In India
Price:	On Request

See full prescribing information for ICLUSIG: Patient Information

Get access ICLUSIG to treat blood cancers on a Named Patient Import Basis.

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to ICLUSIG (ponatinib) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.

IDHIFA (enasidenib) Tablets

Leukemia

Generic Name: (enasidenib). Brand Name: IDHIFA.
IDHIFA (enasidenib) Tablets is used to treat acute myeloid leukemia (AML).

IDHIFA is an isocitrate dehydrogenase-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA approved test.

Brand Name:	IDHIFA
Generic Name:	enasidenib
Strength:	• Tablets: 50 mg or 100 mg
Manufacturer:	Celgene Corporation
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “IDHIFA (enasidenib) Tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Imetelstat for injection

MDS, Blood Disorders, Neuro

Salt Name: imetelstat. It is used to treat patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS).

RYTELO is an oligonucleotide telomerase inhibitor indicated for the treatment of adult patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).

Generic Name:	imetelstat
Strength:	• For injection: 47 mg powder in a single-dose vial for reconstitution. • For injection: 188 mg powder in a single-dose vial for reconstitution.
Manufacturer:	Geron Corporation
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “RYTELO (imetelstat)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for RYTELO (imetelstat) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

IMKELDI (imatinib) oral solution

Leukemia, Blood Disorders

Brand Name: IMKELDI. Generic Name: (imatinib). It is used to treat leukemia (blood cancer).

Imkeldi is used to treat specific types of leukemia (blood cancer), bone marrow disorders, dermatofibrosarcoma protuberans (a rare type of skin cancer), and certain tumors of the stomach and digestive system.

Brand Name:	IMKELDI
Generic Name:	imatinib
Strength:	•
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “IMKELDI (imatinib) oral solution” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Inotuzumab Ozogamicin for Injection

Leukemia

inotuzumab ozogamicin for injection,
for intravenous use Initial U.S. Approval: 2017

Besponsa (inotuzumab ozogamicin) is is a medication used for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Facts about inotuzumab ozogamicin for injection

Disease Indications-Leukemia
Manufacturer-Pfizer Limited
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “inotuzumab ozogamicin for injection” based on the information you provide.

Isatuximab-irfc Injection

Multiple Myeloma

isatuximab-irfc injection
for intravenous use Initial U.S. Approval: 2020

Sarclisa (isatuximab) is a medication used in combination with pomalidomide and dexamethasone or with carfilzomib and dexamethasone for the treatment of adults with relapsed refractory multiple myeloma (RRMM).

Facts about isatuximab-irfc injection

Disease Indications- Multiple Myeloma
Manufacturer- Sanofi
Usage- Intravenous
Medicine Approved By- European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada
Summary of FDA- approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “isatuximab-irfc injection” based on the information you provide.

Ivosidenib Tablets

Leukemia, Bile Duct Cancer, Gastrointestinal

Ivosidenib tablets
for oral use Initial U.S. Approval: 2018

Tibosovo (ivosidenib) is a prescription medicine used to treat adults with an IDH1 mutation who have: Acute myeloid leukemia (AML) that is either newly-diagnosed or relapsed/refractory, or Locally advanced or metastatic bile duct cancer (cholangiocarcinoma).

Facts about ivosidenib tablets

Disease Indications-Leukemia, Bile Duct Cancer
Manufacturer-Servier Pharmaceuticals
Usage-Oral
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ivosidenib Tablets” based on the information you provide.

ixazomib capsules

Multiple Myeloma

ixazomib capsules
for oral use Initial U.S. Approval: 2015

Ixazomib is a medication used for the treatment of multiple myeloma.

Facts about ixazomib capsules

DISEASE INDICATIONS-Multiple Myeloma
MANUFACTURER-Takeda Pharma A/S
USAGE-Oral
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada,
Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ixazomib capsules” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Blood Disorders

hydroxyurea capsules for oral use Initial U.S. Approval: 1967

Facts about hydroxyurea capsules

Access the best support services globally

ibrutinib capsules for oral use Initial U.S. Approval: 2013

Facts about ibrutinib capsules

Access the best support services globally

Brand: ICLUSIG. API: ponatinib is used to treat blood cancers.

Get access ICLUSIG to treat blood cancers on a Named Patient Import Basis.

Generic Name: (enasidenib). Brand Name: IDHIFA. IDHIFA (enasidenib) Tablets is used to treat acute myeloid leukemia (AML).

Salt Name: imetelstat. It is used to treat patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS).

Brand Name: IMKELDI. Generic Name: (imatinib). It is used to treat leukemia (blood cancer).

inotuzumab ozogamicin for injection, for intravenous use Initial U.S. Approval: 2017

Facts about inotuzumab ozogamicin for injection

Access the best support services globally

isatuximab-irfc injection for intravenous use Initial U.S. Approval: 2020

Access the best support services globally

Ivosidenib tablets for oral use Initial U.S. Approval: 2018

Facts about ivosidenib tablets

Access the best support services globally

ixazomib capsules for oral use Initial U.S. Approval: 2015

Facts about ixazomib capsules

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

hydroxyurea capsules
for oral use Initial U.S. Approval: 1967

ibrutinib capsules
for oral use Initial U.S. Approval: 2013

Generic Name: (enasidenib). Brand Name: IDHIFA.
IDHIFA (enasidenib) Tablets is used to treat acute myeloid leukemia (AML).

inotuzumab ozogamicin for injection,
for intravenous use Initial U.S. Approval: 2017

isatuximab-irfc injection
for intravenous use Initial U.S. Approval: 2020

Ivosidenib tablets
for oral use Initial U.S. Approval: 2018

ixazomib capsules
for oral use Initial U.S. Approval: 2015